Skip to main content
animation of illustrated demodex mites holding party favors in front of an illustrated eye
animation of illustrated demodex mites holding party favors in front of an illustrated eye
animation of illustrated demodex mites holding party favors in front of an illustrated eye

Is There aMite Party on Your Eyelids?

If you're experiencing eyelid redness, crusties (collarettes), or irritation, you're not alone.1,2

XDEMVY® can help break up mite parties by targeting and killing the Demodex mites that cause Demodex blepharitis (DB).3,4 If you are unsure about whether you have DB, answer a few questions to uncover its impact on you.

Take Quiz Now See how XDEMVY works

Images are character representations of Demodex mites.

animation of illustrated demodex mites holding party favors in front of an illustrated eye

Images are character representations of Demodex mites.

Is There aMite Party on Your Eyelids?

If you're experiencing eyelid redness, crusties (collarettes), or irritation, you're not alone.1,2

XDEMVY® can help break up mite parties by targeting and killing the Demodex mites that cause Demodex blepharitis (DB).3,4 If you are unsure about whether you have DB, answer a few questions to uncover its impact on you.

Take Quiz Now See how XDEMVY works

See XDEMVY in Action

With a simple swipe, view the impact of XDEMVY treatment on eyelids with DB.

image of before and after treatment with xdemvy image of before and after treatment with xdemvy

BEFORE

AFTER

illustrated demodex mite saying oh no is paralyzed along with text that reads party’s over
References

References: 1. Fromstein S, Harthan J, Patel J, et al. Demodex blepharitis: clinical perspectives. Clin Optom (Auckl). 2018;10:57-63. 2. Trattler W, Karpecki P, Rapoport Y, et al. The prevalence of Demodex blepharitis in US eye care clinic patients as determined by collarettes: a pathognomonic sign. Clin Ophthalmol. 2022;16:1153-1164. 3. XDEMVY. Prescribing Information. Tarsus Pharmaceuticals Inc; 2023. 4. XDEMVY Pivotal Trial Data Presentation. Tarsus Pharmaceuticals Inc.

References: 1. Fromstein S, Harthan J, Patel J, et al. Demodex blepharitis: clinical perspectives. Clin Optom (Auckl). 2018;10:57-63. 2. Trattler W, Karpecki P, Rapoport Y, et al. The prevalence of Demodex blepharitis in US eye care clinic patients as determined by collarettes: a pathognomonic sign. Clin Ophthalmol. 2022;16:1153-1164. 3. XDEMVY. Prescribing Information. Tarsus Pharmaceuticals Inc; 2023. 4. XDEMVY Pivotal Trial Data Presentation. Tarsus Pharmaceuticals Inc.